Search

Your search keyword '"Sliwa T"' showing total 92 results

Search Constraints

Start Over You searched for: Author "Sliwa T" Remove constraint Author: "Sliwa T"
92 results on '"Sliwa T"'

Search Results

1. Lipid levels, atrial fibrillation and the impact of age: Results from the LIPIDOGRAM2015 study

7. PS1331 MYELOMONOCYTIC SKEWING IN CHRONIC MYELOMONOCYTIC LEUKEMIA: PHENOTYPIC, GENOTYPIC AND BIOLOGIC FEATURES AND IMPACT ON SURVIVAL

8. Austrian real world data in elderly and younger metastatic pancreatic cancer patients: Interim results of a multicenter non-interventional study with nab-paclitaxel/gemcitabine

9. Real-World multicenter Austrian analysis of the safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer

11. Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction

12. A MULTICENTER EVALUATION OF THE REVISED 2015 WHO MINOR CRITERIA FOR PREFIBROTIC PRIMARY MYELOFIBROSIS

14. Safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer: a prospective, multicenter non-interventional study

18. P-034 - Austrian real world data in elderly and younger metastatic pancreatic cancer patients: Interim results of a multicenter non-interventional study with nab-paclitaxel/gemcitabine

23. Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox

25. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.

30. An analysis of high-temperature nuclear reactor coupled with gas turbine combined cycle

32. Search for diphoton events with large missing transverse energy in 7 TeV proton-proton collisions with the ATLAS detector

33. Measurement of the inclusive isolated prompt photon cross section in pp collisions at √s=7 TeV with the ATLAS detector

34. Updated Austrian treatment algorithm for metastatic triple-negative breast cancer.

35. Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.

36. Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph + Chronic Myeloid Leukemia.

37. Updated Austrian treatment algorithm in HER2+ metastatic breast cancer.

38. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase p22phox subunit polymorphisms, systemic oxidative stress, endothelial dysfunction, and atherosclerosis in type 2 diabetes mellitus.

39. Austrian recommendations for the management of essential thrombocythemia.

40. Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study.

41. A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting : R-EFECT study.

42. Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients.

43. The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical research.

44. Correction to: Ruxolitinib therapy formyelofibrosis in Austria : Consensus on therapy management.

45. Austrian recommendations for the management of polycythemia vera.

46. Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT3, interleukin 6 and hydrogen peroxide.

47. Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.

48. Diagnosis, management and response criteria of iron overload in myelodysplastic syndromes (MDS): updated recommendations of the Austrian MDS platform.

49. Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.

50. Intensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years.

Catalog

Books, media, physical & digital resources